neulasta
(pegfilgrastim)Amgen Inc
Usage: Neulasta is indicated to reduce the incidence of febrile neutropenia in cancer patients receiving myelosuppressive chemotherapy, and to enhance survival in patients exposed to myelosuppressive doses of radiation. It is not indicated for mobilizing peripheral blood progenitor cells for stem cell transplantation.